Selected research
Market Analysis & Forecast
Global Parathyroid Hormone Market Analysis and Forecast 2026-2032
Market perspective
The global Parathyroid Hormone market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Parathyroid Hormone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Parathyroid Hormone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Parathyroid Hormone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Parathyroid Hormone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Parathyroid Hormone include Sanofi SA, Merck, Eli Lilly, Pfizer, GlaxoSmithKline Plc, Paladin Labs Inc, OSI Pharmaceuticals, Natpara and Cell Genesys Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Parathyroid Hormone, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Parathyroid Hormone, also provides the sales of main regions and countries. Of the upcoming market potential for Parathyroid Hormone, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Parathyroid Hormone sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Parathyroid Hormone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Parathyroid Hormone sales, projected growth trends, production technology, application and end-user industry.
Parathyroid Hormone Segment by Company
Sanofi SA
Merck
Eli Lilly
Pfizer
GlaxoSmithKline Plc
Paladin Labs Inc
OSI Pharmaceuticals
Natpara
Cell Genesys Inc
ALZA Corporation
Abbott Laboratories
Parathyroid Hormone Segment by Type
Hypocalcemia
Hypoparathyroidism
Parathyroid Hormone Segment by Application
Hospitals
Clinics
Other
Parathyroid Hormone Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parathyroid Hormone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Parathyroid Hormone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parathyroid Hormone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Parathyroid Hormone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Parathyroid Hormone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Parathyroid Hormone sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hypocalcemia
- Hypoparathyroidism
Applications
- Hospitals
- Clinics
- Other
Companies covered
- Sanofi SA
- Merck
- Eli Lilly
- Pfizer
- GlaxoSmithKline Plc
- Paladin Labs Inc
- OSI Pharmaceuticals
- Natpara
- Cell Genesys Inc
- ALZA Corporation
- Abbott Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Parathyroid Hormone Market by Type
- 1.2.1 Global Parathyroid Hormone Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Hypocalcemia
- 1.2.3 Hypoparathyroidism
- 1.3 Parathyroid Hormone Market by Application
- 1.3.1 Global Parathyroid Hormone Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospitals
- 1.3.3 Clinics
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Parathyroid Hormone Market Dynamics
- 2.1 Parathyroid Hormone Industry Trends
- 2.2 Parathyroid Hormone Industry Drivers
- 2.3 Parathyroid Hormone Industry Opportunities and Challenges
- 2.4 Parathyroid Hormone Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Parathyroid Hormone Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Parathyroid Hormone Revenue by Region
- 3.2.1 Global Parathyroid Hormone Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Parathyroid Hormone Revenue by Region (2021-2026)
- 3.2.3 Global Parathyroid Hormone Revenue by Region (2027-2032)
- 3.2.4 Global Parathyroid Hormone Revenue Market Share by Region (2021-2032)
- 3.3 Global Parathyroid Hormone Sales Estimates and Forecasts 2021-2032
- 3.4 Global Parathyroid Hormone Sales by Region
- 3.4.1 Global Parathyroid Hormone Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Parathyroid Hormone Sales by Region (2021-2026)
- 3.4.3 Global Parathyroid Hormone Sales by Region (2027-2032)
- 3.4.4 Global Parathyroid Hormone Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Parathyroid Hormone Revenue by Manufacturers
- 4.1.1 Global Parathyroid Hormone Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Parathyroid Hormone Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Parathyroid Hormone Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Parathyroid Hormone Sales by Manufacturers
- 4.2.1 Global Parathyroid Hormone Sales by Manufacturers (2021-2026)
- 4.2.2 Global Parathyroid Hormone Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Parathyroid Hormone Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Parathyroid Hormone Sales Price by Manufacturers (2021-2026)
- 4.4 Global Parathyroid Hormone Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Parathyroid Hormone Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Parathyroid Hormone Manufacturers, Product Type & Application
- 4.7 Global Parathyroid Hormone Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Parathyroid Hormone Market CR5 and HHI
- 4.8.2 2025 Parathyroid Hormone Tier 1, Tier 2, and Tier 3
5 Parathyroid Hormone Market by Type
- 5.1 Global Parathyroid Hormone Revenue by Type
- 5.1.1 Global Parathyroid Hormone Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Parathyroid Hormone Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Parathyroid Hormone Revenue Market Share by Type (2021-2032)
- 5.2 Global Parathyroid Hormone Sales by Type
- 5.2.1 Global Parathyroid Hormone Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Parathyroid Hormone Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Parathyroid Hormone Sales Market Share by Type (2021-2032)
- 5.3 Global Parathyroid Hormone Price by Type
6 Parathyroid Hormone Market by Application
- 6.1 Global Parathyroid Hormone Revenue by Application
- 6.1.1 Global Parathyroid Hormone Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Parathyroid Hormone Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Parathyroid Hormone Revenue Market Share by Application (2021-2032)
- 6.2 Global Parathyroid Hormone Sales by Application
- 6.2.1 Global Parathyroid Hormone Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Parathyroid Hormone Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Parathyroid Hormone Sales Market Share by Application (2021-2032)
- 6.3 Global Parathyroid Hormone Price by Application
7 Company Profiles
- 7.1 Sanofi SA
- 7.1.1 Sanofi SA Company Information
- 7.1.2 Sanofi SA Business Overview
- 7.1.3 Sanofi SA Parathyroid Hormone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Sanofi SA Parathyroid Hormone Product Portfolio
- 7.1.5 Sanofi SA Recent Developments
- 7.2 Merck
- 7.2.1 Merck Company Information
- 7.2.2 Merck Business Overview
- 7.2.3 Merck Parathyroid Hormone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Merck Parathyroid Hormone Product Portfolio
- 7.2.5 Merck Recent Developments
- 7.3 Eli Lilly
- 7.3.1 Eli Lilly Company Information
- 7.3.2 Eli Lilly Business Overview
- 7.3.3 Eli Lilly Parathyroid Hormone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Eli Lilly Parathyroid Hormone Product Portfolio
- 7.3.5 Eli Lilly Recent Developments
- 7.4 Pfizer
- 7.4.1 Pfizer Company Information
- 7.4.2 Pfizer Business Overview
- 7.4.3 Pfizer Parathyroid Hormone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Pfizer Parathyroid Hormone Product Portfolio
- 7.4.5 Pfizer Recent Developments
- 7.5 GlaxoSmithKline Plc
- 7.5.1 GlaxoSmithKline Plc Company Information
- 7.5.2 GlaxoSmithKline Plc Business Overview
- 7.5.3 GlaxoSmithKline Plc Parathyroid Hormone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 GlaxoSmithKline Plc Parathyroid Hormone Product Portfolio
- 7.5.5 GlaxoSmithKline Plc Recent Developments
- 7.6 Paladin Labs Inc
- 7.6.1 Paladin Labs Inc Company Information
- 7.6.2 Paladin Labs Inc Business Overview
- 7.6.3 Paladin Labs Inc Parathyroid Hormone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Paladin Labs Inc Parathyroid Hormone Product Portfolio
- 7.6.5 Paladin Labs Inc Recent Developments
- 7.7 OSI Pharmaceuticals
- 7.7.1 OSI Pharmaceuticals Company Information
- 7.7.2 OSI Pharmaceuticals Business Overview
- 7.7.3 OSI Pharmaceuticals Parathyroid Hormone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 OSI Pharmaceuticals Parathyroid Hormone Product Portfolio
- 7.7.5 OSI Pharmaceuticals Recent Developments
- 7.8 Natpara
- 7.8.1 Natpara Company Information
- 7.8.2 Natpara Business Overview
- 7.8.3 Natpara Parathyroid Hormone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Natpara Parathyroid Hormone Product Portfolio
- 7.8.5 Natpara Recent Developments
- 7.9 Cell Genesys Inc
- 7.9.1 Cell Genesys Inc Company Information
- 7.9.2 Cell Genesys Inc Business Overview
- 7.9.3 Cell Genesys Inc Parathyroid Hormone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Cell Genesys Inc Parathyroid Hormone Product Portfolio
- 7.9.5 Cell Genesys Inc Recent Developments
- 7.10 ALZA Corporation
- 7.10.1 ALZA Corporation Company Information
- 7.10.2 ALZA Corporation Business Overview
- 7.10.3 ALZA Corporation Parathyroid Hormone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 ALZA Corporation Parathyroid Hormone Product Portfolio
- 7.10.5 ALZA Corporation Recent Developments
- 7.11 Abbott Laboratories
- 7.11.1 Abbott Laboratories Company Information
- 7.11.2 Abbott Laboratories Business Overview
- 7.11.3 Abbott Laboratories Parathyroid Hormone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Abbott Laboratories Parathyroid Hormone Product Portfolio
- 7.11.5 Abbott Laboratories Recent Developments
8 North America
- 8.1 North America Parathyroid Hormone Market Size by Type
- 8.1.1 North America Parathyroid Hormone Revenue by Type (2021-2032)
- 8.1.2 North America Parathyroid Hormone Sales by Type (2021-2032)
- 8.1.3 North America Parathyroid Hormone Price by Type (2021-2032)
- 8.2 North America Parathyroid Hormone Market Size by Application
- 8.2.1 North America Parathyroid Hormone Revenue by Application (2021-2032)
- 8.2.2 North America Parathyroid Hormone Sales by Application (2021-2032)
- 8.2.3 North America Parathyroid Hormone Price by Application (2021-2032)
- 8.3 North America Parathyroid Hormone Market Size by Country
- 8.3.1 North America Parathyroid Hormone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Parathyroid Hormone Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Parathyroid Hormone Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Parathyroid Hormone Market Size by Type
- 9.1.1 Europe Parathyroid Hormone Revenue by Type (2021-2032)
- 9.1.2 Europe Parathyroid Hormone Sales by Type (2021-2032)
- 9.1.3 Europe Parathyroid Hormone Price by Type (2021-2032)
- 9.2 Europe Parathyroid Hormone Market Size by Application
- 9.2.1 Europe Parathyroid Hormone Revenue by Application (2021-2032)
- 9.2.2 Europe Parathyroid Hormone Sales by Application (2021-2032)
- 9.2.3 Europe Parathyroid Hormone Price by Application (2021-2032)
- 9.3 Europe Parathyroid Hormone Market Size by Country
- 9.3.1 Europe Parathyroid Hormone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Parathyroid Hormone Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Parathyroid Hormone Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
- 9.3.9 Nordic Countries
10 China
- 10.1 China Parathyroid Hormone Market Size by Type
- 10.1.1 China Parathyroid Hormone Revenue by Type (2021-2032)
- 10.1.2 China Parathyroid Hormone Sales by Type (2021-2032)
- 10.1.3 China Parathyroid Hormone Price by Type (2021-2032)
- 10.2 China Parathyroid Hormone Market Size by Application
- 10.2.1 China Parathyroid Hormone Revenue by Application (2021-2032)
- 10.2.2 China Parathyroid Hormone Sales by Application (2021-2032)
- 10.2.3 China Parathyroid Hormone Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Parathyroid Hormone Market Size by Type
- 11.1.1 Asia Parathyroid Hormone Revenue by Type (2021-2032)
- 11.1.2 Asia Parathyroid Hormone Sales by Type (2021-2032)
- 11.1.3 Asia Parathyroid Hormone Price by Type (2021-2032)
- 11.2 Asia Parathyroid Hormone Market Size by Application
- 11.2.1 Asia Parathyroid Hormone Revenue by Application (2021-2032)
- 11.2.2 Asia Parathyroid Hormone Sales by Application (2021-2032)
- 11.2.3 Asia Parathyroid Hormone Price by Application (2021-2032)
- 11.3 Asia Parathyroid Hormone Market Size by Country
- 11.3.1 Asia Parathyroid Hormone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Parathyroid Hormone Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Parathyroid Hormone Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Parathyroid Hormone Market Size by Type
- 12.1.1 SAMEA Parathyroid Hormone Revenue by Type (2021-2032)
- 12.1.2 SAMEA Parathyroid Hormone Sales by Type (2021-2032)
- 12.1.3 SAMEA Parathyroid Hormone Price by Type (2021-2032)
- 12.2 SAMEA Parathyroid Hormone Market Size by Application
- 12.2.1 SAMEA Parathyroid Hormone Revenue by Application (2021-2032)
- 12.2.2 SAMEA Parathyroid Hormone Sales by Application (2021-2032)
- 12.2.3 SAMEA Parathyroid Hormone Price by Application (2021-2032)
- 12.3 SAMEA Parathyroid Hormone Market Size by Country
- 12.3.1 SAMEA Parathyroid Hormone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Parathyroid Hormone Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Parathyroid Hormone Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Parathyroid Hormone Value Chain Analysis
- 13.1.1 Parathyroid Hormone Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Parathyroid Hormone Production Mode & Process
- 13.2 Parathyroid Hormone Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Parathyroid Hormone Distributors
- 13.2.3 Parathyroid Hormone Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst